Valuation: DIAGNOS Inc.

Market Cap 4.7Cr 3.41Cr 2.92Cr 2.73Cr 2.5Cr 326.32Cr 4.76Cr 32Cr 13Cr 163.93Cr 13Cr 13Cr 542.2Cr P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 4.64Cr 3.37Cr 2.89Cr 2.7Cr 2.47Cr 322.67Cr 4.7Cr 32Cr 12Cr 162.09Cr 13Cr 12Cr 536.14Cr EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
95.32%
Yield 2025 *
-
Yield 2026 -
1 day+0.65%
1 week+4.00%
Current month+41.82%
1 month+69.57%
3 months+110.81%
6 months+36.84%
Current year+4.00%
1 week 0.38
Extreme 0.375
0.42
1 month 0.28
Extreme 0.275
0.42
Current year 0.18
Extreme 0.175
0.42
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Chairman 69 30/10/2025
Director/Board Member 72 28/09/2020
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Option

Director

-3,57,143 0.2966%
30/07/26 Buy

Director

53,571 0.0445%
30/07/26 Buy

Director

50,000 0.0415%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+4.00%+50.00%-21.21% 3.41Cr
+0.85%+0.58%-2.65%+64.34% 22TCr
+3.58%+1.17%+69.09%+113.73% 12TCr
+2.17%+4.74%-28.52%-41.24% 11TCr
-0.78%-1.26%-27.27%-32.58% 8.7TCr
+0.02%+5.79%-26.14%+3.86% 6.22TCr
+0.80%-0.87%-26.25%-20.62% 4.74TCr
+1.48%+0.98%+3.61%+105.67% 3.98TCr
+1.10%-1.65%+2.73%+214.05% 3.88TCr
+1.50%-0.23%-12.11%+12.87% 3.68TCr
Average +1.06%-1.19%+0.25%+39.89% 7.63TCr
Weighted average by Cap. +1.07%-0.19%-1.69%+42.13%

Financials

2025 2026
Net sales 1L 75.38T 64.57T 60.42T 55.31T 72.13L 1L 7L 3L 36.23L 3L 3L 1.2Cr 65.48T 47.55T 40.74T 38.11T 34.89T 45.5L 66.34T 5L 2L 22.86L 2L 2L 75.6L
Net income -42.86L -31.13L -26.67L -24.95L -22.84L -30Cr -43.43L -2.95Cr -1.15Cr -15Cr -1.17Cr -1.14Cr -49Cr -45.55L -33.08L -28.34L -26.52L -24.27L -32Cr -46.15L -3.13Cr -1.22Cr -16Cr -1.24Cr -1.22Cr -53Cr
Net Debt -2L -1L -1L -95.29T -87.23T -1.14Cr -2L -11.26L -4L -57.14L -4L -4L -1.89Cr -5L -4L -3L -3L -3L -3.65Cr -5L -36.12L -14.08L -1.83Cr -14.32L -14.01L -6.06Cr
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
21/26/21 CA$0.3900 +0.65% 1,67,500
20/26/20 CA$0.3875 -3.13% 1,45,310
19/26/19 CA$0.4000 +2.56% 2,18,300
18/26/18 CA$0.3900 -1.27% 1,31,003
17/26/17 CA$0.3950 +5.33% 2,70,391

Annual profits - Rate of surprise